Korro Bio (KRRO)

• Market cap: $384M
• 1 day: 12.24%
• 5 days: 5.17%
• 1 month: -14.58%
• 3 months: 173.46%
• 6 months: 130.48%
• Year to date: -0.27%
• 1 year: -28.85%
• 5 years: -96.12%
• 10 years: -94.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Employees: 92